The Government of India's restriction on ashwagandha leaves in nutritional supplements is sparking industry debate. Experts weigh safety, science, and supply chain impacts of the root-only directive.

India’s Ministry of Ayush and Food Safety and Standards Authority of India have issued aligned directives prohibiting ashwagandha leaves in supplements and foods, reinforcing root-only use, mandating plant-part labeling, and stepping up enforcement after years of non-compliance.

The updated CITES resource aims to provide AHPA members with the most current regulatory information to support compliance efforts.

Naturally Informed's Growth and Innovation Forum will feature curated educational programming covering high-growth areas shaping the natural products marketplace.

Take a look at how the Nutrify Today team is connecting global markets in the nutraceuticals space. 

FDA said the public meeting will help inform the agency's next steps regarding the meaning of the dietary supplement ingredient categories defined in DSHEA.

Honoring the CEO of AIDP, who had a vision to elevated standards within the natural products industry, and looking at what is next for the AIDP and Threotech.

Take a look at how the SupplySide Connect portfolio is evolving.

In addition to calling out now-discredited research, AHPA refuted repeated claims  that dietary supplements are "not well regulated" by FDA.

The question is not whether Americans should choose food or supplements, but how both can responsibly work together to support health, CRN said in response to a NYT article questioning the need for dietary supplements.